Novel ET mutations: stuck in the MPL with you

摘要

In this issue of Blood, Levy et al report on how novel mutations in the transmembrane (TM) domain of the thrombopoietin (TPO) receptor cause familial essential thrombocythemia and intriguingly link their potential mechanisms of action with that of receptor agonists.(1)